USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Med-el Elektromedizinische Geraete GmbH

USPTO PatentsView assignee record - 195 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Med-el ranks #2,037 of 49,997 tracked US assignees by granted-patent volume, with 195 patents across 29 technology areas.

#2,037
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.7/100)
15.0
avg claims per patent
-64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2037 · Foreign Corporation #2,037 · 195 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 195 grants
  • TOP-DECILE #2,037/49,997
  • PHOTO-FINISH China Mobile…
  • CPC-FOCUS A61N · 29 areas
  • INNOV-PAR 48.7/100
  • CLAIMS-RICH 15.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -64% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: China Mobile Communications Group Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Med-el

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Med-el's Innovation Score is 48.7/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Med-el's grants concentrate

Med-el Elektromedizinische Geraete GmbH is a focused PatentsView assignee: 29 CPC subclasses with 88.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2017 (38 grants) versus a trough of 2 in 2023. By volume, Med-el sits between True Velocity IP Holdings, Inc. and Forcepoint LLC.

Med-el's three-year grant acceleration

From 2019–2021 to 2022–2024, Med-el Elektromedizinische Geraete GmbH moved from 52 to 19 grants (0.36x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,923. See the growth leaderboard.

Who files at Med-el's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Med-el holds 195 patents at rank #2,037, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Med-el

By rank, the assignees closest to #2,037 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Med-el's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Med-el, neither rank-band nor same-CPC leaders (those blocks stay above).

Med-el's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Med-el Elektromedizinische Geraete GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 30 15.4%
2016 35 17.9%
2017 38 19.5%
2018 17 8.7%
2019 20 10.3%
2020 15 7.7%
2021 17 8.7%
2022 12 6.2%
2023 2 1.0%
2024 5 2.6%
2025partial year 4 2.1%

Which technologies does Med-el Elektromedizinische Geraete GmbH patent most?

Top 15 of 29 technology areas

Where it ranks

Overall rank by patents

#2,037

of 49,997 tracked assignees

Innovation Score

48.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Med-el Elektromedizinische Geraete GmbH's patent record in context - here's where to go next.

  • Med-el Elektromedizinische Geraete GmbH's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 88.2% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #2,037 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Med-el Elektromedizinische Geraete GmbH against True Velocity IP Holdings, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.